Robots, drugs and fees: The key trends that have shaped ETFs
By Louise Hill, 18 Aug 17
The last 10 years have seen ETF products grow from pre-teens to fully fledged adults, even dabbling with drugs along the way. 7IM’s passive expert and senior investment manager Peter Sleep looks back at the biggest trends.
It has worked particularly well for the ETFs tracking major equity indexes where fees for major FTSE 100, S&P 500 and Eurostoxx trackers have fallen from an average of 0.4% to 0.07%.
Sleep said: “The ETF issuers denied the allegation of a price war, but I am not sure that anyone believed them and we all benefitted.
Capitalism is a great thing and it guaranteed enough competition that the major FTSE 100, S&P 500 and Euro Stoxx ETFs’ fees have fallen.”